Quantcast
Home > Quotes > HOLX
HOLX

Hologic, Inc. Common Stock (HOLX) Quote & Summary Data

$38.01
*  
0.25
0.65%
Get HOLX Alerts
*Delayed - data as of Aug. 21, 2018 10:42 ET  -  Find a broker to begin trading HOLX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    HOLX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 38.01 / $ 38.02
1 Year Target
47
Today's High / Low
$ 38.40 / $ 37.97
Share Volume
230,999
50 Day Avg. Daily Volume
2,226,751
Previous Close
$ 38.26
52 Week High / Low
$ 45.09 / $ 35.10
Market Cap
10,377,145,829
P/E Ratio
NE
Forward P/E (1y)
17.08
Earnings Per Share (EPS)
$ -0.31
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.25

Intraday Chart

Shares Traded

Share Volume:
230,999
50 Day Avg. Daily Volume:
2,226,751

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
17.08
Earnings Per Share (EPS):
$ -0.31

Trading Range

The current last sale of $38.01 is 8.29% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 38.40 $ 45.09
 Low: $ 37.97 $ 35.10

ETFs with HOLX as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
1.5% Invesco S&P 500 Equal Weight Health Care ETF (RYH) +18.18 (10.20%)
0.05% Nationwide Maximum Diversification U.S. Core Equity ETF (MXDU) +3.54 (13.81%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. On March 22, 2017, we acquired Cynosure, Inc., or Cynosure. Cynosure is a developer, manufacturer and supplier of a broad array of light-based aesthetic and medical treatment systems. The products are used to provide a diverse range of treatment applications such as non-invasive body contouring, hair removal, tattoo removal, skin revitalization and scar reduction, as well as the treatment of vascular lesions. The Cynosure business is referred to as Medical Aesthetics and operates as a separate business segment. As a result of our acquisition of Cynosure, we operate in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health.  ... More ...  


Risk Grade

Where does HOLX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 38.35
Open Date:
Aug. 21, 2018
Close Price:
$ 38.26
Close Date:
Aug. 20, 2018

Consensus Recommendation

Analyst Info